Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-25-009626
Filing Date
2025-08-14
Accepted
2025-08-14 15:06:52
Documents
92
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q canna_10q.htm   iXBRL 10-Q 1162322
2 FORBEARANCE AGREEMENT canna_ex48.htm EX-4.8 40136
3 CERTIFICATION canna_ex311.htm EX-31.1 11965
4 CERTIFICATION canna_ex312.htm EX-31.2 12230
5 CERTIFICATION canna_ex32.htm EX-32 5468
  Complete submission text file 0001654954-25-009626.txt   5897588

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA isdr-20250630.xsd EX-101.SCH 69551
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE isdr-20250630_lab.xml EX-101.LAB 335315
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE isdr-20250630_cal.xml EX-101.CAL 56407
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isdr-20250630_pre.xml EX-101.PRE 305699
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE isdr-20250630_def.xml EX-101.DEF 189824
96 EXTRACTED XBRL INSTANCE DOCUMENT canna_10q_htm.xml XML 956140
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

EIN.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 251217879
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)